Abstract
s S77 Conclusions: Overall, ROSAE is considered to be a highly valuable or valuable experience (78%) for trainees. However, the growing number of requests has led to the adoption of institution-specific practices to provide coverage. Forty nine percent of programs do not provide ROSAE coverage for all FNA procedures, 82% of programs use a combination of pathology personnel to provide coverage that includes residents and cytotechnologists. Twenty four percent of programs use telepathology and 27% have future intentions for its use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
